专题：Colorectal Cancer Treatments and Studies

This cluster of papers represents advancements in the research and treatment of colorectal cancer, focusing on topics such as the use of cetuximab and bevacizumab, the impact of KRAS and BRAF mutations, the efficacy of chemotherapy, and the development of molecular subtypes for precision medicine. It also explores the role of EGFR inhibitors and the molecular mechanisms underlying metastatic colorectal cancer.
最新文献
Cardiovascular adverse events associated with epidermal growth factor receptor tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer: systematic review and network meta-analysis

review Full Text OpenAlex

CLDN18.2–targeting antibody–drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trial

article Full Text OpenAlex

Comprehensive revenue comparison of pure robotic vs. hybrid robotic surgery for sigmoid colon and rectosigmoid cancer

article Full Text OpenAlex

Phase I clinical trial of the bifunctional EGFR/TGF-β fusion protein ficerafusp alfa (BCA101) alone and in combination with pembrolizumab for advanced solid tumors

article Full Text OpenAlex

Circulating Tumor DNA as a Novel Prognostic Biomarker of Therapeutic Efficacy in Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial Infusion

article Full Text OpenAlex

Patterns in genomic mutations among patients with early-onset colorectal cancer: an international, multicohort, observational study

article Full Text OpenAlex

Defactinib with avutometinib in patients with solid tumors: the phase 1 FRAME trial

article Full Text OpenAlex

Cracking the EGFR Code: Cancer Biology, Resistance Mechanisms, and Future Therapeutic Frontiers

review Full Text OpenAlex

Impact of age and sex on the efficacy and safety of ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy: a subgroup analysis of the ARMANI phase III trial

article Full Text OpenAlex

Abstract LB1-07: Exploratory Biomarker Analysis of the Phase 3 KEYNOTE-522 Study of Neoadjuvant Pembrolizumab or Placebo Plus Chemotherapy Followed by Adjuvant Pembrolizumab or Placebo for Early-Stage TNBC

article Full Text OpenAlex

近5年高被引文献
Diagnosis and Treatment of Metastatic Colorectal Cancer

review Full Text OpenAlex 1912 FWCI54.173

Global colorectal cancer burden in 2020 and projections to 2040

review Full Text OpenAlex 1908 FWCI78.09

Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

article Full Text OpenAlex 1413 FWCI123.273

PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer

article Full Text OpenAlex 1180 FWCI218.442

Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

article Full Text OpenAlex 1107 FWCI151.789

Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial

article Full Text OpenAlex 982 FWCI77.921

Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

article Full Text OpenAlex 812 FWCI159.52

Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

article Full Text OpenAlex 752 FWCI103.112

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer

article Full Text OpenAlex 716 FWCI88.129

Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study

article Full Text OpenAlex 681 FWCI119.336